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ABSTRACT
Diabetes mellitus is characterized by hyperglycemia, oxidative stress and excessive
production of intermediary metabolites including methylglyoxal (MGO), a reactive carbonyl.
MGO can readily interact with proteins, lipids and DNA, and cause an imbalance of the cellular
antioxidant system leading to carbonyl stress. The effects of MGO can be devastating if the
targeted molecules are responsible for the maintenance of membrane potentials and ionic
homeostasis. Here we show that MGO disrupts the vascular isoform of ATP-sensitive K+ (KATP)
channels by acting on the mRNAs of Kir6.1 and SUR2B subunits thereby regulating vascular
tone. Our results show that the 3’ untranslated region (UTR) of Kir6.1 mRNA and the coding
region of SUR2B mRNA are targeted by MGO causing a disruption of vascular KATP channels.
The destabilization of the mRNAs of KATP channel can in turn affect K+ homeostasis of vascular
smooth muscles as well as vascular responses to circulating vasodilators and vasoconstrictors.

INDEX WORDS: Kir6.1, SUR2B, Hyperglycemia, Methylglyoxal, MGO, Reactive carbonyl
species, Carbonyl stress, Vascular tone, Potassium channels, Untranslated region, Coding region,
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1. INTRODUCTION
1.1 Reactive carbonyl species
Carbonyl species are compounds containing the (C=O) carbonyl functional group. As
oxygen atom in the carbonyl group is more electronegative than the carbon atom, it pulls the
electrons from the carbon atom and thereby increases the polarity of the carbonyl group. The
carbonyl carbon is electrophilic in nature and readily reacts with nucleophiles. The carbonyls
methylglyoxal (MGO), glyoxal, acrolein, hydroxyhexenal, hydroxynonenal (HNE) are highly
reactive compared to other carbonyls produced in the biological system (Ellis, 2007). These
carbonyls are collectively called reactive carbonyl species (RCS). RCS are more stable than the
free radicals, and can diffuse over long distances to reach its target molecules (Lesgards et al.,
2011).
1.2 Carbonyls in pathological conditions
Diabetes mellitus is a systemic disorder that affects 8.3% of the population in the United
States (Department of Health and Human Services, 2011). Persistent hyperglycemia in diabetic
patients causes metabolic alterations, leading to overproduction of a variety of intermediary
metabolites. One of the metabolites is the reactive α,β-dicarbonyl, MGO which is both an
aldehyde and a ketone. MGO has been attributed to be responsible for the development and
progression of diabetes and diabetes associated vascular complications (Bourajjaj et al., 2003)
like atherosclerosis, ischaemia, hypertension, retinopathy and nephropathy (Brownlee, 2001). All
of the diabetes associated vascular complications are characterized by a variety of changes in the
micro and macro vasculatures. Most of these changes are due the impairment of the appropriate
response of the vasculatures to vascoactive substances, hormones, neurotransmitters, cytokines
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etc. The changes in the vasculature can be one of the following or a consortium of many.
Abnormal function of the vasculature and high potential for thrombosis can lead to
atherosclerosis. Inflammation, presence of high levels of oxidants and stiffening of the
vasculature and improper expression of surface markers are also markers for vascular
complications (Creager et al., 2003). In Alzheimer’s disease an increase in the levels of acrolein,
HNE and acrolein modified proteins have been identified (Lovell et al., 2001). Increased levels
of HNE and HNE modified proteins have also been identified in hypertension (Asselin et al.,
2006). HNE has also been identified in atherosclerotic plaques (Leonarduzzi et al., 2005). MGO
is also thought to be present in the amyloid plaques (Kuhla et al., 2005).
1.3 Production of MGO
MGO is produced via both enzymatic and non-enzymatic reactions. MGO is mainly
produced via glucose metabolism, through the transformation of triosephosphate intermediates –
glyceraldehyde-3-phosphate (GAPDH) and dihydroxy acetone phosphate (DHAP) (Cooper,
1984; Pompliano et al., 1990; Thornalley, 1990) by methylglyoxal synthase. MGO is also
formed by the metabolism of aminoacetone or acetone from lipolysis, which is catalyzed by
semicarbazide-sensitive amine oxidase (SSAO) and acetol monooxygenase (Casazza et al., 1984;
Lyles and Chalmers, 1992). This conversion can also happen via a non-enzymatic reaction in
which aminoacetone is converted to MGO in the presence of Fe+2 as catalyst (Dutra et al., 2001).
Additionally MGO is also formed during the cellular metabolic process like protein metabolism
(Lyles and Chalmers, 1992). Proteins containing L-threonine undergo oxidation in the
mitochondria to form glycine and acetyl-CoA via the intermediate 2-amino-3-oxobutyrate (Bird
et al., 1984). In case of diabetes, 2-amino-3-oxobutyrate is driven towards formation of
aminoacetone, a precursor for MGO production (Kalapos, 2008).
2

All forms of diabetes are associated with hyperglycemia and increase in the levels of
reactive oxygen species (ROS) like superoxide anion (O2-), hydroxyl ion (OH-), and non-radical
reactive species like hydrogen peroxide (H2O2). Increased levels of intracellular oxidants can
lead to the peroxidation of membrane lipids (Esterbauer et al., 1991), which can lead to the
generation of carbonyl species like MGO, through a series of oxidative and rearrangement
reactions (Esterbauer et al., 1982). Reducing sugars can react with the amino groups of Lys and
Arg residues on proteins to form Schiff’s bases via a Maillard reaction. The Schiff bases can
undergo a series of rearrangement reactions to form advanced glycation end products (AGEs)
(Thornalley et al., 1999). Oxidation of the thus formed AGEs leads to the generation of carbonyl
species like MGO, glyoxal, acrolein (Thornalley, 2005). Under hyperglycemic conditions
increased flux through the polyol - fructose pathway is observed which leads to the formation of
MGO (Desai et al., 2010).
1.4 Reactivity of MGO
MGO is highly reactive due to the presence of the ketone group at C2 in addition to the
aldehyde group at C1. The carbonyl groups are electrophilic and can undergo addition with the
nucleophilic groups on proteins, DNA, RNA and lipids (Cooper et al., 1987; Marnett et al.,
1985).

1.4.1 Protein modification by MGO
The carbonyl groups (aldehyde/ketone) of MGO can react with the amino group (NH4+)
on the amino acids Lys and Arg to form Schiff bases (compounds containing C=N), the
formation of which are reversible. The Schiff bases can undergo a series of acid or base
catalyzed isomerization reactions that lead to the formation of Amadori products (rearranged
Schiff’s base in which the nitrogen in C=N is bound by a hydrogen atom from the adjacent OH-).
3

The Amadori products can further undergo a series of condensation, oxidation in presence of
metals and dehydration reactions to AGEs (Wautier and Schmidt, 2004). MGO reacts with the
Arg and Lys residues on proteins to form the AGEs 5-hydro-5-methylimidazolones (Thornalley
et al., 2003), argypyrimidine (Shipanova et al., 1997) and Nɛ-carboxymethyl lysine, Nɛcarboxyethyl lysine (Ahmed et al., 2002) adducts respectively. Additionally the carbonyl groups
of MGO can also react with the sulphydryl groups (-SH) on the Cys residues on proteins to form
glycation adducts (Sato et al., 1980). The protein glycation adducts are stable and thus pose
problems for the normal functioning of the biological system.

1.4.2 Modification of nucleotides by MGO
MGO preferentially reacts with the NH2 groups present on the guanine nucleotides to
form tricyclic compounds (Vaca et al., 1994). MGO reacts with the deoxyguanidine (dG)
nucleotides

to

form

3-(2′-deoxyribosyl)-6,7-dihydro-6,7-dihydroxy-6-methylimidazo-[2,3-

b]purine-9(8)one and N2-(1-carboxyethyl)-deoxyguanosine (Papoulis et al., 1995; Schneider et
al., 1998). To differentiate from the MGO derived protein adducts, the MGO adducts formed
with the nucleotides are called nucleotide AGEs.
MGO preferentially reacts with the single stranded nucleotides, RNA and denatured
DNA. This is because the guanine nucleotides in native DNA molecules are protected from the
electrophilic attack of MGO due to the double stranded structure (Krymkiewicz, 1973).
1.5 Metabolism of MGO
Irrespective of the production pathway, MGO is detoxified and maintained at normal
levels in the cell by the glyoxalaseI/II system in presence of reduced glutathione (GSH).
Glyoxalase I enzyme converts the MGO-GSH adducts into S-lactoylglutathione, following
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which glyoxalase II enzyme converts S-lactoylglutathione into harmless D-lactate and releases
the GSH (Chang and Wu, 2006) for the next round of detoxification.
In addition to the glyoxalase system, several other enzymes exist that facilitate the
metabolism of MGO to other relatively harmless compounds. MGO contains two functional
groups that can undergo either oxidation or reduction. MGO is also a substrate for the aldehyde
dehydrogenase family of enzymes (ALDH2, ALDH3 and ALDH5), which can oxidize MGO
into carboxylic acids (Vasiliou et al., 2004). This conversion also provides a protective role
against oxidative stress (Ohsawa et al., 2003) in addition to carbonyl stress. Cytochrome P450
enzymes also facilitate the oxidation of the toxic aldehydes like MGO to carboxylic acids
through hydroxylation of C-H bonds (Ellis, 2007). The enzymes aldehyde reductase (AKR 1A)
and aldose reductase (AKR 1B) belonging to the family of aldo-keto reductases (AKR) play a
role in reducing the aldehyde to alcohols, converting MGO to acetol and D-lactaldehyde (Vander
Jagt et al., 1992). Alcohol dehydrogenase enzymes (ADH) are known to reduce the unsaturated
double bond in the aldehydes to detoxify the aldehydes into alcohols (Hartley et al., 1995).
1.6 Carbonyl Stress
Under pathological conditions the levels of RCS exceed way above the normal levels as a
consequence of the presence of increased amounts of the precursor molecules like plasma
glucose, L-threonine, fructose, lipid peroxidation products and oxidants. Additionally in many
pathological conditions the carbonyl detoxification system is impaired at the DNA or protein
level (Thornalley, 2003). This leads to an accumulation of RCS, due to a failure in the clearance
of RCS from the cell. This imbalance in the production and clearance of RCS leads to the
phenomenon called carbonyl stress. Excess RCS are not only cytotoxic but can also act as
mediators of oxidative stress and as secondary cytotoxic messengers (Lesgards et al., 2011).
5

Modification of proteins by RCS is more rapid compared to the modifications by its precursor
glucose (Lo et al., 1994) even when present in low concentrations. MGO and MGO derived
molecules have been identified as indicators of carbonyl stress in vivo (Baynes and Thorpe,
1999).
1.7 MGO toxicity
MGO can readily react with proteins and lipids leading to disruption of functional
molecules and can cause structural damages to transporters, ion channels, transcription factors,
signaling molecules and plasma membranes (Picklo et al., 2002). Double stranded DNA
continuously opens up and closes throughout its structure thereby creating and closing gaps
continously. MGO can bind to DNA at such gaps and can form DNA-MGO adducts
(Krymkiewicz, 1973). These reactions proceed via reactions involving free radicals (Lo et al.,
2006). The guanine residues on DNA and RNA can be targeted by MGO, which can lead to
abnormalities in replication and transcription processes (Wu, 2006).
MGO reacts with the proteins to form AGEs/AGE precursor molecules (Thornalley et al.,
1999). AGEs are involved in the pathogenesis associated with vascular complications related to
many vascular diseases (Rosca et al., 2005). AGE precursors affect the target cells by several
mechanisms. AGEs react with many intracellular proteins and alter the protein structure and
function. AGE precursors can modify some of the extracellular matrix components, which can
react abnormally with the receptors and structural components of the matrix on the cells. AGEs
on extracellular matrix (ECM) interfere with the normal matrix-matrix and matrix-cell
interactions. AGE induced crosslinks can alter the structure and function of the intact blood
vessels by making them less elastic and more permeable (Brownlee, 2001). AGEs primarily
target the structural components mainly collagen IV, fibrinogen, myelin, tubulin (Vlassara,
6

1996). Hydroimidazolone adducts formed by MGO can react with Type IV collagen in the
vascular basement membrane and disrupt the integrin binding sites on the collagen (Vlassara,
1996). This leads to endothelial shedding and results in excess amounts of circulating endothelial
cells (ECs). Increase in the circulating ECs is an indication of vascular damage associated with
diabetes and uremia. MGO or AGE precursors can modify the plasma proteins in the cell to form
AGEs. AGEs effect the cellular function by binding to specific receptors called receptors for
advanced glycation end products (RAGE). RAGE are present on ECs, vascular smooth muscle
cells (VSMCs), cardiac myocytes, macrophages and monocytes (Thornalley, 1998). Increased
expression of RAGE on VSMCs and ECs has been observed in diabetes (Schmidt et al., 1999) .
AGE receptor-ligand interaction induces ROS production and activates NF-κB transcription
factor causing unwanted changes in the gene expression several cytokines and growth factors
like TNF-α, TGF-β, GMCSF, pro-inflammatory molecules, cell adhesion molecules molecules
like VCAM-1, that effects the cell-cell and cell-matrix communication (Brownlee, 2001).
Glycated proteins are resistant to protein degradation mechanisms and can lead to the
accumulation of AGEs in local environments (Brownlee, 1995). AGEs increase the levels of
diacyl glycerol (DAG) which can activate different isoforms of PKC. Activated PKC has been
shown to inhibit the KATP channel (Yang et al., 2008).
AGEs act on the –SH groups of antioxidant detoxifying enzymes like glyoxalase I
(Thornalley, 2003)

and superoxide dismutase (SOD) (Desai and Wu, 2008), glutathione

reductase (Vander Jagt et al., 1997), to inactivate the enzymes. MGO can lower the levels of
intracellular antioxidant - GSH leading to an imbalance in the oxidant-antioxidant ratio in the
cells to cause oxidative stress (Thornalley, 2003). This leads to an overall decrease in the levels
of functional antioxidant enzymes and leads to an impairment of the ROS and RCS clearance.
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1.8 Carbonyl stress vs. Oxidative stress
MGO induced toxicity has been attributed to the presence of free radicals in both MGO
generation and degradation processes (Kalapos, 2008). The enzymatic formation of
methylglyoxal from aminoacetone yields H2O2, whereas a non-enzymatic conversion of
aminoacetone to methylglyoxal releases O2-. Enzymatic conversion of acetol to methylglyoxal
produces H2O2. Auto-oxidation and photolysis of MGO in the presence of OH- has been reported
to produce acetyl radicals (Nukaya et al., 1993). The ROS produced during MGO production can
contribute to initiate or elevate cellular oxidative stress in the absence of appropriate
detoxification systems. Oxidative stress is known to be associated with many cardiovascular
diseases like diabetes, atherosclerosis, ischaemia, hypertension, aging, retinopathy, Alzheimers,
end stage renal failure, inflammation (Ellis, 2007). In addition, oxidative stress can also lead to
the production of several reactive aldehydes and ketones and thus contribute to carbonyl stress.
Indeed, recent studies have shown that reactive carbonyls, rather than the initial ROS, are
responsible for diabetic vascular complications (Ellis, 2007). Thus the relation between the
generation of RCS and ROS is intertwined. The production of one kind of reactive species can
lead to the generation of the other.
1.9 Maintenance of the vascular tone
Vascular tone is regulated by the combined action of several neuronal, hormonal
mechanisms in addition to the local metabolic state of the cells to maintain homeostasis.
Disruption of this regulation leads to cellular dysfunction and leads to the progression of severe
diseases including diabetes associated macrovascular and microvascular complications,
atherosclerosis, ischemia, hyperemia, shock and hypertension (Gutterman et al., 2005; Webb,
2003). Blood vessels are made of ECs and smooth muscle cells (SMCs) which maintain the
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vascular structure and function. The ECs form the blood vessel lumen as they are positioned
between the circulating blood and the vessel wall. The SMCs are wrapped around the ECs and
generate the force required to constrict or dilate the blood vessels. Acting on either the vascular
endothelium, smooth muscle or both, the regulation of vascular tone is achieved by a
complicated signaling network involving circulating hormones, neurotransmitters and
metabolites (Liu and Gutterman, 2009).
1.10 Effect of MGO on the vasculature
Increased levels of MGO have been observed in patients with vascular diseases. Most of
the vascular diseases are associated with initial changes in the vascular permeability followed by
structural remodeling of the vasculature. Patients with Type-I diabetes mellitus have a 5-6 fold
increase in plasma levels of MGO whereas patients with Type-II diabetes mellitus, have a 2-3
fold increase (McLellan et al., 1994). Previous studies have shown that plasma MGO levels
range from 14.2 µM to 33.6 µM in healthy rats (Wang et al., 2004). Several orders of elevation
in the MGO levels are expected to take place with persistent hyperglycemia (Chang and Wu,
2006). The MGO levels may be even higher in local tissues than in the plasma as a result of
immediate release from cells. Indeed, the MGO levels are as high as 300 µM when measured in
cultured mammalian cells (Chaplen et al., 1998). The exact mechanism by which MGO alters the
structure and function of the vasculature is unknown. Impaired endothelial dependent
vasorelaxation and an increase in the contractility of the vasculature have been observed in
human and animal models for hypertension. Dysfunction of the vascular tone is also associated
with diabetes, which is characterized by altered metabolic states like hyperglycemia, excess fatty
acid availability and insulin resistance. Hyperglycemia causes a decrease in the endothelial nitric
oxide (NO) production, and also increases the chances of VSMC proliferation. Being highly
9

reactive, MGO can react with the –SH and NH4+ groups on the proteins present on the VSMCs
and ECs on the walls of the blood vessels, thereby interfering with the normal functioning of the
vasculature. Altered Ca+2 homeostasis has been observed in VSMCs and ECs in animal models
treated with MGO (Vasdev et al., 1998). Despite the accumulating evidence for the adverse
effects of MGO, the mechanisms and the molecular targets through which MGO regulates the
function of VSMs remain to be demonstrated.
1.11 Control of vascular tone
VSMCs are excitable in nature. Membrane potentials of VSMCs determine the muscle
contractility (Wray et al., 2005). KATP channels are present on the plasma membranes of SMCs.
Closure of KATP channels in response to changes in metabolic state causes membrane
depolarization. Membrane depolarization leads to the activation of voltage-dependent Ca+2
channels (VDCC) raising cytosolic Ca+2 levels. The increase in intracellular Ca+2 induces the
release of more Ca+2. Intracellular Ca+2 binds to calmodulin to form a Ca+2 – calmodulin
complex. This complex binds to myosin light-chain kinase (MLCK) and activates it. Activated
MLCK, in turn phosphorylates the myosin light-chain (Herring et al., 2006), which interacts with
the actin and causes smooth muscle contraction (Wray et al., 2005). On the contrary,
hyperpolarization reduces the activity of the VDCC, lowers the intracellular Ca+2 levels, and
eventually results in the relaxation of vascular SMCs. Owing to its critical role in maintaining
vascular tone, KATP channel is modulated by a number of vasoactive substances and metabolites.
1.12 KATP channels
ATP sensitive K+ channels (KATP) channels are present on excitable cells like cardiac
myocytes, pancreatic β cells, skeletal muscle, vascular SMCs and neurons. Functional KATP
channels are octamers made up of two different types of subunits, four Kir6.x (inwardly
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rectifying potassium channel) and four sulphonyl urea receptor (SURx) subunits that belong to
the ABC family of transporters. The KATP channel pore is formed by the Kir6.x (Kir6.1 or
Kir6.2) subunits. The Kir6.x subunits consist of two transmembrane domains (TMDs) linked by
a pore loop. The SURx subunit exists in two isoforms SUR1 and SUR2. Each SUR isoform has
different splice variants. The SURx subunit consists of three membrane spanning domains
(MSD) and two nucleotide binding domains (NBDs). ATP binds to the two NBDs in the SUR
subunit and is hydrolyzed. ATP hydrolysis by NBD generates the energy required for the
conformational change of the MSD domains, which further produce the force required for the
gating of the pore forming Kir subunit. KATP channels are inhibited by ATP and activated by
nucleotide diphosphate (NDP) e.g., MgADP. By sensing the ATP and NDP levels, KATP
channels couple cellular metabolism to membrane excitability. Different possible combinations
of the Kir6.x and SURx subunits exist, giving rise to a variety of KATP channels with different
physiological roles. Kir6.2/SUR2A channels are observed in cardiac and skeletal muscle whereas
Kir6.1/SUR2B channels are found in VSMCs. Disruption of the KATP channels can have severe
consequences as knockout of the Kir6.1 gene in mice leads to coronary vasospasm and sudden
death (Chutkow et al., 2002; Miki et al., 2002). In diabetic patients, the vascular response to
KATP channel openers is impaired, resulting in a defect in vasodilation (Desai et al., 2010; Miura
et al., 2003).
1.13 Cell’s response to stress conditions
A cell responds to stress by regulating several key components of the cellular machinery.
Cells respond to stimuli like extreme temperatures, oxidants, inflammation, and exposure to
endotoxins, harmful metabolites and genotoxins by implementing a series of adaptive responses
known as the cellular stress responses. The main player in the cellular stress response is the
11

regulation of expression levels of a number of genes. The gene expression can be regulated at the
transcriptional level or by post-transcriptional regulatory mechanisms affecting the stability of
and translational efficiency of the mRNA (Brennan and Steitz, 2001; Fan et al., 2002). Although
cells have mechanisms for the regulation of the mRNA turnover rate to meet their functional
needs, transcriptional inhibition and mRNA instability can have severe consequences on cellular
function and survival.
1.14 MGO causes a decrease in the expression of vascular KATP channels
The detrimental effect of MGO has been observed in a range of pathologies. Previously
studies were carried out to investigate the role of MGO in the development of vascular
complications. Experiments were carried out to test the effect of endogenously produced
metabolite MGO on the expression levels of vascular KATP channels. qPCR experiments were
carried out to study the levels of Kir6.1 and SUR2B mRNA in MGO treated A-10 smooth
muscle cell line (which endogenously express Kir6.1/SUR2B vascular isoform of the KATP
channels) (Shi et al., 2010). A-10 cells were treated with varying concentrations of MGO for a
12 h period. Following MGO treatment the total RNA was extracted and was subsequently
analyzed by regular PCR and qPCR techniques.
Regular PCR analysis showed a clear decrease in the levels of Kir6.1 and SUR2B
mRNAs following a 300 µM MGO treatment. Higher doses of MGO (1 mM) lead to nearly a
total loss in the levels of Kir6.1 and SUR2B mRNAs. However, the mRNA levels of the internal
control GAPDH did not show a significant change in response to similar MGO treatments (Fig.
1A). This suggests that the effect of MGO on the mRNAs is not global but is specific only to
Kir6.1 and SUR2B mRNAs. qPCR analysis following MGO treatment showed that the levels of
Kir6.1 and SUR2B mRNAs decreased in a concentration dependent manner. The IC50 for Kir6.1
12

and SUR2B mRNAs was found to be 350 μM and 290 μM respectively (Fig. 1B and C). The
effect mediated by MGO on the levels of Kir6.1 and SUR2B mRNAs was also found to be timedependent. The levels of Kir6.1 and SUR2B mRNAs followed a time dependent decrease in
response to a 500 μM MGO treatment. The time constant for the mRNA reduction was 1.15 h for
Kir6.1 and 0.33 h for SUR2B mRNAs respectively (Fig. 1D and E). (Yang et al., 2011 in review)
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Figure 1. Prolonged exposure to MGO causes a decrease in the levels of Kir6.1 and SUR2B mRNAs
A. Regular PCR analysis showed a decrease in the levels of Kir6.1 and SUR2B mRNAs on exposure to
300 μM and 1 mM MGO treatment. The levels of GAPDH mRNA showed no detectable change. CTL,
control. B-E. qPCR analysis of Kir6.1 and SUR2B mRNA following MGO treatment. B, C. Reduction in
the levels of Kir6.1 and SUR2B mRNA after a 12 h treatment with 300 μM and 1 mM MGO. Kir6.1 IC50
= 350 μM and SUR2B IC50 = 290 μM. D, E. MGO mediated decrease in the levels of Kir6.1 and SUR2B
mRNAs followed a time-dependence with a time constant τ, 1.15 h for Kir6.1 and 0.33 h for SUR2B.
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1.15 MGO causes a suppression of the vascular KATP channel currents
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Figure 2. Prolonged treatments with MGO led to vascular KATP channel inhibition
A. KATP channel current activated by pinacidil. B, C. Reduction in the pinacidil-induced KATP channel
current in response to 1 mM MGO exposure for 3 h and 22 h respectively. D. Summary of the
quantitation of pinacidil-induced vascular KATP channel currents in control and MGO treatment (22 h, 1
mM). E. Summary of the quantitation of KATP channel currents described as a function of time, with the
time constant 3 h.

A reduction in the levels of Kir6.1 and SUR2B mRNAs has a major impact on the overall
function of the vascular KATP channels. This was determined by the study of whole cell currents
in HEK293 cells in which the vascular Kir6.1/SUR2B channel was heterologously expressed.
The KATP channel currents were activated by an exposure to pinacidil (Pin, KATP channel opener)
(Fig. 2A) that were suppressed by glibenclamide (Glib, KATP channel blocker), followed by an
exposure to 1 mM MGO for 3 h (Fig. 2B). Increasing the MGO exposure time to 22 h nearly
abolished the KATP channel currents (Fig. 2C). Quantitation of the KATP channel currents after a 1
14

mM MGO treatment for 22 h showed a ~90% reduction with a 3 h time constant (Fig. 2D and E)
which suggests a functional significance of the effect of MGO on the KATP channel activity
(Yang et al., 2011 in review).

1.16 Inhibition of transcription vs. mRNA destabilization
To determine if the decrease in the levels of Kir6.1 and SUR2B mRNAs was due to
transcriptional inhibition or mRNA instability further experiments were carried out. A-10 smooth
muscle cells with actinomycin D (AcD), a transcriptional inhibitor for different time periods.
Subsequent PCR analysis showed that the AcD treatment alone did not cause a decrease in the
levels of Kir6.1 and SUR2B mRNAs. When MGO (300 µM) and AcD (5 µg/ml) were applied
together, a decrease in the mRNA levels of both Kir6.1 and SUR2B (but not GAPDH) was
observed. This effect was similar to the effect shown by MGO treatment alone on Kir6.1 and
SUR2B mRNAs. This suggests that MGO mediated decrease in the levels of Kir6.1 and SUR2B
mRNAs is not due to suppression of transcription but due to the direct targeting of the KATP
channel mRNAs by MGO (Fig. 3A). (Yang et al., 2011 in review).
Quantitation of the mRNA levels of Kir6.1 showed a decrease in the levels of Kir6.1
mRNA in response to AcD alone whereas a greater extent of reduction was observed following
MGO alone treatment (Fig. 3B). The levels of SUR2B mRNA marginally decreased with AcD
alone whereas a MGO alone treatment caused a dramatic decrease in the levels of SUR2B
mRNA (Fig.3D). However the combined treatment of AcD and MGO did not enhance the
reduction kinetics of Kir6.1 and SUR2B mRNAs compared with MGO treatment alone (Fig. 3C
and E) suggesting that the decrease in the levels of Kir6.1 mRNA is due to mRNA instability
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mediated by the action of MGO but not as a consequence of transcriptional inhibition. (Yang et
al., 2011 in review).
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Figure 3. Inhibition of transcription vs. mRNA destabilization
Inhibition of transcription vs. mRNA destabilization causing a reduction in the levels of Kir6.1 and
SUR2B mRNAs. A, Gel images of the reverse transcribed PCR products of GAPDH, Kir6.1 and SUR2B
mRNAs from A10 cells treated with AcD (A), AcD and MGO (AM) and MGO alone (M) for different
time periods (1, 3 and 6 h, respectively) denoted as a numerical following each treatment condition. CTL,
control. B-E. qPCR analysis of Kir6.1 and SUR2B mRNAs following AcD, MGO and combined
treatment of AcD and MGO (AM) at different time points.
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1.17 mRNA stability
The stability of mRNA has a great impact on the response of the cell to a particular
stimulus. The mRNA turnover rate can influence the overall protein levels in the cell. The
stability of the mRNA is dependent on cis-stability elements present on the mRNA and also
other trans-acting factors. These stability determinants can determine the stability of the mRNA
by acting in unison with each other or by acting independently of the other. The cis-stability
determinants identified on the mRNA are the 5’ – guanosine cap, 5’ untranslated region (UTR),
open reading frame destabilizing sequences, 3’UTR and a stretch of adenosine residues - poly
(A) tail.
The 5’guanosine cap present at the 5’end provides resistance to the mRNA from general
ribonucleases. This resistance is due to the presence of 5’–5’ phosphodiester bond. The removal
of the 5’guanosine cap, will make the mRNA vulnerable to the 5’–3’ exoribonucleases or
endoribonucleases. The 5’ UTR sequence also determines the translational efficiency of the
mRNA. If the mRNA is bound by ribosomes, and is being translated, the stability of the mRNA
increases. In other words, actively translated mRNA is more stable compared to the ones that are
not being translated. In addition the 5’ UTR can have one or more internal loops that prevent the
advancing ribosome to move beyond the loop. The coding region of the mRNA has been
identified to have stability determining sequences. c-fos mRNA has been identified to have
destabilizing sequences in the open reading frame (Shyu et al., 1991). These destabilizing
sequences are purine rich sequences and have been identified as targets for at least two cellular
proteins. The binding of the cellular proteins to the purine rich sequence initiates mRNA
degradation (Chen et al., 1992).
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The 3’UTR of the mRNAs has been long studied for their role in determining the stability
of the mRNAs. The sequences in the 3’UTR’s of the mRNAs can form stem loops that prevent
them from being regulated normally. For example the histone mRNA has a 6 bp stem at the near
end of the 3’ terminal followed a stretch of poly (A). This stem loop was identified to be
essential in rendering the histone mRNA stable. It is also possible that some binding proteins
might be binding the histone mRNA at the stem loop and thereby causing the stability of the
mRNA (Ross, 1995). Conserved stability determining sequences have been identified in the 3’
UTRs of different mRNAs. The well-studied stability sequences in the 3’UTRs are the iron
responsive element (IRE) present on the iron transporting transferrin mRNA and the stretch of
adenylate and uridylate residus (AURE), AUUUA pentamer present in multiple repeats on the
mRNAs of cytokines, growth factors and lymphokines. Owing to their presence on the mRNAs
coding for important proteins in the cellular function, AUREs are considered important in
determining the stability of the mRNAs. The 3’UTR of the c-fos mRNA was identified to have
an AURE. When the 3’UTR of the c-fos mRNA was replaced with the 3’UTR of v-fos mRNA,
there was an accumulation of the c-fos mRNAs following serum stimulation, whereas the c-fos
mRNA levels dropped significantly when the 3’UTR of c-fos was placed downstream of the
coding region of c-fos indicating that the AURE containing 3’UTR of c-fos mRNA was
responsible for determining the stability of c-fos mRNA. Additionally the AURE can also
function as stabilizing signals in many mRNAs. Many cytoplasmic and nuclear proteins have
been identified to bind to the AUREs of the mRNAs to influence the stability of the mRNAs
(Brennan and Steitz, 2001).
The poly (A) tail of the mRNA has been widely known for conferring stability to the
mRNA. Poly (A) tails present at the end of the mRNA was initially thought to give protection to
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the 3’ terminus of the mRNA from ribonucleases. Deadenylation is the first step in initiating
mRNA degradation from the 3’terminus. Poly (A) tails are specifically bound by Poly (A)
binding proteins (PABP) that protect the mRNA from deadenylation. In the absence of the poly
(A) tail the half lived of mRNAs have been observed to be significantly reduced. It has also been
determined that poly (A) tails increases the translational efficiency of the mRNA by interacting
with the translation initiation and elongation factors docked at the 5’ terminus of the mRNA. The
stability of the mRNA increases, when the mRNA is actively transcribed. Thus in the absence of
poly (A) tail the translational efficiency would be compromised leading to a decrease in the
stability of the mRNA (Ross, 1995).
In addition to the cis-stability determinants present on the mRNA, several trans-acting
factors like ions, growth factors, hormones, metabolites can also affect the stability of the mRNA
by binding to the cis-stability determinants (Sachs, 1993).
1.18 Significance
Although MGO is known to be a major player in vascular complications and vascular
inflammation state, its vascular targets and mechanisms of action are still unclear. The
membrane proteins responsible for maintaining the contractility, membrane potentials and
membrane properties of the ECs and VSMCs can be regulated by MGO. The vascular KATP
channel is a potentially important target of MGO in vasculatures. Disruption of functional KATP
channels will lead to abnormalities in cellular excitability, VSM contraction and impairment of
vascular responses to vasoconstrictors and vasodilators. Therefore, we performed these studies to
test the hypothesis that MGO affects the function of vascular KATP channels by destabilization of
Kir6.1 and SUR2B mRNAs because MGO is known to preferentially bind to and react with
single stranded nucleotides. Our results showed that MGO treatment caused disruption of both
19

Kir6.1 and SUR2B mRNAs through two distinct mechanisms. Such an effect is likely to impair
membrane potentials and K+ homeostasis of VSMs thereby causing vascular dysfunction, seen in
many vascular diseases. Membrane potential appears to be one of the mechanisms (Liu and
Gutterman, 2002) that can lead to a disruption of the cellular homeostasis. Depolarization can
open the voltage-activated Ca2+ channels leading to Ca2+ influx (Anzai et al., 2000; Wray et al.,
2005). Since K+ channels are the primary regulators of membrane potentials, inhibition of the K+
channels results in depolarization and an elevation in intracellular Ca2+ (Cook et al., 1988). Since
several NADPH oxidases for ROS production are stimulated by elevated intracellular Ca2+
(Brandes et al., 2010; Guzik et al., 2008; Hink et al., 2001; Zhang et al., 2008), and since RCS
and ROS share the antioxidant detoxification systems, sustained depolarization may augment the
production of these reactive species and aggravate oxidative/carbonyl stress. Thus the
understanding of the regulation of vascular tone will have a strong influence on designing
treatments for the vascular diseases.
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Figure 4. Working hypothesis summarizing the effect of MGO on cellular homeostasis
Hyperglycemia leads to the production of MGO. MGO causes a reduction in the expression levels of
vascular KATP channels by causing mRNA instability of Kir6.1 and SUR2B mRNAs. Loss of functional
KATP channels causes depolarization of the membrane potential, which in turn activates voltage dependent
calcium channels (VDCC). Activated VDCC leads to an influx of Ca +2 into the cytosol. Increased
cytosolic Ca+2 activates the Ca+2 dependent NADPH oxidase (NOX), which aids in the production of ROS
from the mitochondria. ROS produced can further modulate the KATP channels and thereby augment the
existing carbonyl and oxidative stress. Increased cytosolic Ca+2 can also lead to abnormal SMC
contractility. Glucose is transported into the cell by the GLUT I, glucose transporter.
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2. MATERIALS AND METHODS
2.1 Genomic DNA isolation
Sprague Dawley rat (Jackson lab) tail tissue was used for isolating the genomic DNA
using the DNeasy Blood and Tissue kit (Qiagen) following manufacturer’s protocol.
2.2 Amplification of the 3’ UTR’s of Kir6.1 and SUR2 mRNA
Primer pairs with a 5’–XhoI overhang for the 3’ UTRs of Kir6.1/SUR2 genes were
designed based on the conserved sequences from rat genomic sequence (Accession
no.AC_000072.1). PCR was performed in a 20 µl reaction containing 1 µg of isolated genomic
DNA, 0.75 mM dNTPs, 2.5 µl DMSO, Pfu ultra buffer at final concentration of 1X, 25 nM of
primer mixture, 1 µl of Pfu ultra DNA polymerase using Mastercycler (Eppendorf Pro S) with
an initial denaturation period of 95 °C for 2 min, followed by 36 cycles of denaturation at 95 °C
for 50 s, annealing at 60 °C for 45 sec, and extension at 72 °C for 2 min, with a final elongation
at 72 °C for 10 min. The PCR products were analyzed on a 2% agarose gel.
Table 1: List of primers for amplification of the 3’UTRs of Kir6.1 and SUR2B mRNAs
Target
gene

Accession
No.

Primer sequence

Kir6.1

NM_017099.3

Fw: ACCGCTCGAGCCTCCATCCGGAGGAATAAC
Re: ACCGCTCGAGCGTCTTCACAAGACTCCCACAC

SUR2

NM_013040.2

Fw: ACCGCTCGAGCGCTGACCTGGTCATTGTGATG
Re: ACCGCTCGAGCGCAGGTGAATCCTACCGATAC

Amplicon
length (bp)
1000

2600

Note: Primers were designed to include the ACCGCTCGAG overhang. Xho I consensus sequence is
underlined.
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2.3 pmirGLO luciferase reporter vector
The pmirGLO expression vector (Promega) was designed to quantitatively evaluate the
effect endogenously present or exogenously introduced compounds/factors on a specific gene.
The vector backbone includes a firefly luciferase gene (luc2) under the control of PGK promoter,
a multiple cloning site (MCS) downstream of luc2. Additionally the vector contains a renilla
(hRluc-neo) gene under the control of SV40 promoter. The gene of interest to be studied for
targeting by miRNAs or other compounds is cloned downstream of luc2 gene. luc2 serves as a
primary reporter gene, a decrease in the firefly luciferase expression indicates that the gene
cloned into the reporter vector is targeted by compound/factor under study. hRluc-neo gene
serves as a control reporter for normalization process.
2.4 Cloning of the 3’UTRs of Kir6.1 and SUR2B mRNA to pmirGLO luciferase reporter
vector
The pmirGLO expression was digested with XhoI restriction enzyme (restriction site
located downstream of the firefly - luc2 gene) and gel purified with QIAquick gel extraction kit
(Qiagen) according to the manufacturer’s instructions. The appropriate PCR products for 3’UTR
of Kir6.1 and SUR2B were purified using the QIAquick PCR purification kit (Qiagen). The
purified fragments were digested with XhoI enzyme followed by purification of the digested
fragments. Ligation was performed in a 10 µl volume, 50 ng of digested vector and 300 ng of
digested fragment were incubated with 400 U of T4 DNA ligase (M0202S, NEB) for 16 h at 16
°C. The ligated products were transformed into XL1-blue competent cells (Agilent) for
amplification and the amplified DNA was obtained through plasmid Mini-preparation (Qiagen).
The constructs were confirmed by DNA sequence analysis.
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2.5 Cell culture
Rat vascular smooth muscle cells (A-10, CRL-1476, ATCC, Manassas, VA) were
cultured as a monolayer and grown to 80-90% confluence in a 35 mm petri dish in
DMEM/10%FBS in a humidified 5% CO2 atmosphere at 37 °C.
2.6 Transfection of A-10 cells and MGO treatment
A 35 mm petri dish of cells was transfected with 1 µg Kir6.1 or SUR2B 3’UTR
containing pmirGLO luciferase reporter vector using Fugene 6 transfection reagent (Roche
Applied Science, Indianapolis, IN). The cells were dissociated with trypsin (0.25%) after 8-12 h
of transfection and were seeded into 96-well plate for further growth. MGO treatment (in
triplicates) was performed after 18-24h. The cells were treated with 75 μl of 10, 30, 100 and 300
µM MGO freshly prepared in DMEM/10%FBS for 5 h following which luciferase reporter assay
was performed.
2.7 Luciferase assay
Luciferase reporter assay was performed using the Dual-Glo luciferase assay system
(Promega), 5 h after the MGO treatment. Briefly, a 75 μl of Dual-Glo substrate equal to the
volume of the MGO containing culture medium was added to each well and mixed. The firefly
luminescence was measured using a luminometer (Model 1420 Victor3V, Perkin Elemer,
Waltham, MA) after a 15-20 min incubation period. After obtaining the firefly luciferase
reading, 75 μl of Dual Glo Stop & Glo reagent equal to the volume of original culture medium
was added to each well and the renilla luminescence was measured after 15-20 min. The ratio of
firefly: renilla luciferase was calculated for each well. The sample well ratio was normalized to
the control well ratio.
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2.8 In vitro transcription of Kir6.1 and SUR2B genes
cDNA sequences of rat Kir6.1 (GenBankTM No. D42145) and mouse SUR2B
(GenBankTM No. D86038, mRNA isoform NM_011511) were previously cloned into pcDNA
3.1cloning vector. Linear template DNA required for in vitro transcription experiments was
obtained by using a restriction site downstream of the cDNA insert on the pcDNA 3.1. The in
vitro transcription reactions were performed in RNase free environment with MEGAscript T7
high yield transcription kit (Ambion). For the in vitro transcription reaction, 1 µg of linearized
template DNA was incubated with 8 µl of the NTP mixture, 2 µl of 10X reaction buffer and 2 µl
of T7 enzyme mix in a 20 µl reaction at 37 °C for 4 h. The in vitro transcribed RNA was
recovered by adding 30 µl of Lithium chloride precipitation solution to the in vitro transcription
reaction mixture and chilled at -20 °C for 4 h. The RNA was pelleted by centrifugation at 4 °C
for 15 min at 13,000 rpm. The RNA pellet was washed once with 70% ethanol, re-centrifuged
and the supernatant was discarded. The RNA pellet was dissolved in appropriate volume of
RNase free H2O.
2.9 Exposure of in vitro transcribed Kir6.1 or SUR2B mRNA to MGO
MGO was diluted to the required concentrations in RNase free H2O from a 5.5 M stock
solution. For the MGO treatment, 2 µg of RNA was treated with 10 µl of MGO (100, 300 and
600 µM) at 37 °C for 6, 18 or 24 h time periods.
2.10 Determination of the effect of MGO on Kir6.1 or SUR2B mRNA
After MGO treatment, 95% formamide containing gel loading buffer was added to the
MGO + RNA mixture and heat denatured at 65 °C for 45 min followed by chilling on ice. The
denatured RNA was resolved on a 1.5% agarose gel and visualized with ethidium bromide under
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UV-fluorescence. The RNA band intensity on the gel was determined by densitometry analysis
using ImageJ (Abramoff, 2004).
2.11 Data Analysis
Data are presented as the mean ± S.E. Differences in means tested with Student’s t test or
analysis of variance (ANOVA) and were accepted as significant if P ≤ 0.05.
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3. SPECIFIC AIM
To demonstrate that MGO exposure causes a disruption of the mRNAs of Kir6.1 and
SUR2B subunits of the vascular isoform of the KATP channels, leading to impairment of function
K+ currents.
This aim was addressed by a series of studies. The 3’ UTR of mRNA is considered to be
a major determinant of the stability of the mRNA. The 3’ UTRs of Kir6.1 and SUR2B mRNAs
were amplified from the respective genomic DNA and cloned to a luciferase reporter vector
(pmirGLO) to study the effect of MGO on the 3’ UTRs of Kir6.1 and SUR2B mRNAs. In
addition to the 3’ UTR, the coding region and 5’ UTR of the mRNA are also known to contribute
to the stability of the mRNA. The mRNAs of Kir6.1 and SUR2B subunits of the vascular K ATP
channel were synthesized by in vitro transcription reactions. The in vitro synthesized mRNAs
were treated with varying concentrations of MGO and the effect of MGO on the mRNAs of
Kir6.1 and SUR2B was determined by resolving the MGO treated mRNAs with gel
electrophoresis and the mRNA bands were visualized under UV-fluorescence. The variation in
the mRNA bands of MGO treated and non-treated samples was quantified using ImageJ, an
image processing program.
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4. RESULTS
4.1 MGO acts on the 3’UTR of KATP channel mRNAs
The stability of a mRNA largely relies on its 3’ UTR (Ross, 1995). To study the effect of
MGO on the 3’ UTR of Kir6.1 and SUR2B mRNAs, a luciferase reporter vector was used. The
3’UTRs of Kir6.1 and SUR2B were cloned into the pmirGLO luciferase vector and the A-10
cells were transfected with Kir6.1 or SUR2B 3’UTR containing luciferase vector. The effect of
MGO on the luciferase expression in the transfected cells was determined with Dual-Glo
luciferase assay system, 5 h after MGO (10, 30, 100 and 300 µM) treatment.
A-10 cells transfected with Kir6.1-3’UTR containing luciferase vector, showed a
concentration-dependent reduction in the luciferase reporter signal (Fig. 5A). A treatment with
300 µM MGO led to a maximum decrease in the luciferase activity in the A-10 cells by 28.8 ±
5.3% (P < 0.001; n = 5) compared with the control. The difference in the luciferase activity
observed in the cells treated with MGO from that of the control luciferase activity was
statistically significant. A decrease in the luciferase activity by 15.2 ± 2.9% (P < 0.05; n = 5)
and 4.5 ± 3.5% (n = 4) was observed in A-10 cells treated with 100 μM and 10 µM MGO,
respectively.
In contrast, A-10 cells transfected with SUR2B-3’UTR containing luciferase vector did not
show a similar response to the same set of MGO treatments. The decrease in the luciferase
activity in response to MGO treatment was not statistically significant (Fig. 5B).
Therefore, it is likely that MGO acts on the 3’UTR of Kir6.1 mRNA causing its instability
while MGO may mediate its effect on SUR2B mRNA stability via a different mechanism
instead.
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Figure 5. MGO acts on the 3’UTRs of KATP channel mRNAs
A-10 cells transfected with Kir6.1-3’UTR or SUR2B-3’UTR containing luciferase reporter vector
(pmirGLO) were treated with different concentrations of MGO respectively and the luciferase gene
expression from the reporter vector was measured after 5 h. The ratio of firefly (experimental reporter) :
renilla (control reporter) luciferase was calculated for each well. The sample well ratio was normalized to
the control well ratio and is represented on the Y- axis as the amount of luciferase activity in response to
different MGO treatments along with the control. A. Summary of the effect of different concentrations
(10 μM, 100 μM and 300 μM) of MGO on the luciferase activity of Kir6.1-3’UTR containing luciferase
reporter vector. B. Summary of the effect of different concentrations (30, 100 and 300 μM) of MGO on
the luciferase activity of SUR2B-3’UTR containing luciferase reporter vector. *, P < 0.05; ***, P < 0.001;
n = 4 experiments.
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4.2 MGO suppresses the activity of KATP channels by directly acting on regions other than
the 3’UTRs on Kir6.1 and SUR2B subunit mRNAs
Since MGO has been shown to interact directly with nucleic acids (Krymkiewicz, 1973) to
form adducts, we tested the possibility that the coding sequences of the Kir6.1/SUR2B mRNA
are targeted by MGO, leading to mRNA degradation. Kir6.1 and SUR2B mRNAs synthesized by
in vitro transcription reactions were then treated with 100, 300 and 600 μM MGO for 18 h time
period. The change in the mRNA levels of Kir6.1 and SUR2B following MGO treatment was
resolved by gel electrophoresis and visualized with ethidium bromide under UV-fluorescence.
Obvious reduction in the band density of SUR2B mRNA was seen with 300 µM MGO
treatments, and the decrease in the SUR2B mRNA band was more prominent with 600 µM
MGO treatment (Fig. 6B top panel). MGO mediated mRNA instability may also result in a
reduction in the size of the mRNA. Thus, we elongated the image obtained from UVfluorescence in a vertical orientation to determine if there is any difference in the migration
distance of MGO treated mRNA samples compared with the control. This shows that SUR2B
mRNA treated with 600 µM MGO migrated a slightly longer distance compared with that of
control mRNA (Fig. 6B bottom panel) and hence the mRNA band lay lower on the gel with
respect to the control band. This indicates that SUR2B mRNA may be degraded upon MGO
treatment and thus resulted in a band slightly smaller in size compared with the control.
Similar experiments were also performed on in vitro transcribed Kir6.1 mRNA. Kir6.1
mRNA treated with increasing doses of MGO does not show a significant change in the RNA
levels compared with the control (Fig. 6A)
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Figure 6. MGO suppresses the activity of KATP channels by directly acting on regions other than the
3’UTRs on Kir6.1 and SUR2B subunit mRNAs
Kir6.1 and SUR2B mRNAs were synthesized by in vitro transcription reaction and were treated with
different concentrations of MGO. A, B. (top panel) Gel image of Kir6.1 and SUR2B mRNAs treated with
100 µM, 300 µM and 600 µM MGO respectively, along with untreated mRNA, control (CTL) for 18 h
obtained from UV – fluorescence. (bottom panel) Vertical elongation images of Kir6.1 and SUR2B gel
images from the corresponding top panels. The dashed line represents the position of the band from the
control sample, at which the mRNA bands were analyzed for change in migration distance and density.
The RNA band sizes on the RNA marker are labeled.

Taken together these results suggest that MGO acts on the mRNAs of SUR2B subunit at
regions other than the 3’ UTR and causes a decrease in the SUR2B mRNA levels, whereas a
significant decrease in mRNA levels of Kir6.1 subunit was not observed.
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4.3 MGO mediates dose dependent decrease in the levels of SUR2B mRNA
The decrease in the mRNA levels of SUR2B following MGO treatment was noted if the
density of the mRNA bands from MGO treated samples decreased compared with the control
sample following gel electrophoresis and visualization with UV- fluorescence. The change in the
mRNA band density in MGO treated mRNA samples compared with the control sample was
quantified using by densitometry analysis of the RNA bands using ImageJ image processing
program.SUR2B mRNA was treated with increasing concentrations (100, 300 and 600 μM
MGO) for different time points.
Following a 6 h MGO exposure a marginal decrease in the levels of SUR2B mRNA band
density was observed in response to increasing concentrations of MGO (Fig. 7A). A decrease in
the band density by 4.6 ± 0.8% (n = 4) was observed with 100 μM MGO treatment. A further
increase in the MGO concentration to 300 and 600 μM, lead to a decrease in the mRNA band
density by 6.9 ± 1.0% (n = 4) and 7.7 ± 1.5% (n = 4) respectively.
At an 18 h time point (Fig. 7B), a 600 µM MGO treatment led to a pronounced decrease in
the SUR2B mRNA band density compared to the control value (61.4 ± 3.2%, P < 0.001; n = 4).
Treatment with lower concentrations of MGO produced a smaller, but significant decrease by
43.4 ± 6.4% (P < 0.001; n = 4) with 300 µM MGO whereas a 14.4 ± 2.9 % (n = 4) decrease was
observed with 100 µM MGO.
At 24 h time point (Fig. 7C), a 600 μM MGO treatment lead to a drastic decrease in the
levels of SUR2B mRNA by 84.3 ± 1.2% (P < 0.001; n = 4) compared with the control.
Treatment with lower concentrations of MGO produced a decrease in the SUR2B mRNA band
density by 68.0 ± 4.4% (P < 0.001; n = 4) with 300 μM and 50.1 ± 7.1% (P < 0.001; n = 4) with
100 μM MGO.
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Figure 7. MGO mediates dose dependent decrease in the levels of SUR2B mRNA
Summary of Net quantitation (NQ) of SUR2B mRNA following MGO treatment (100, 300, and 600 µM).
A. Exposure time 6 h. B. Exposure time 18 h. C. Exposure time 24 h. ***, P < 0.001; n = 4 experiments.

Taken together, these results suggest that MGO mediated decrease in the levels of
SUR2B mRNA is dependent on the concentration of MGO. Higher concentration (600 μM) of
MGO leads to a greater reduction in the density of the SUR2B mRNA band compared with 300
μM and 100 μM MGO treatment.
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4.4 SUR2B mRNA levels decrease with an increase in the MGO exposure time
To determine the time-dependence for the effect of MGO on SUR2B mRNA levels, SUR2B
mRNA was treated with 300 and 600 µM MGO for 6, 18 and 24 h (Fig. 8).
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Figure 8. SUR2B mRNA levels decrease with an increase in the MGO exposure time
Summary of NQ of SUR2B mRNA at different exposure times (6, 18 and 24 h) following MGO
treatment. A. MGO concentration, 300 μM. B. MGO concentration, 600 μM. ***, P < 0.001; n = 4
experiments.

A 300 μM MGO treatment (Fig. 8A) caused a marginal decrease in the levels of SUR2B
mRNA by 6.9 ± 1.0% (n = 4) after a 6 h MGO exposure, while an exposure to MGO for 18 h and
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24 h caused graded decreases in the SUR2B mRNA levels by 43.4 ± 6.4% (P < 0.001; n = 4) and
68.0 ± 4.4% (P < 0.001; n = 4), respectively.
With a 600 μM MGO treatment (Fig. 8B), a similar pattern of reduction compared to the 300
μM MGO treatment was observed after 6, 18 and 24 h exposure times. A slight decrease in the
levels of SUR2B mRNA by 7.7 ± 1.5% (n = 4) after a 6 h MGO exposure, while the MGO
exposure for 18 h and 24 h enhanced the reduction in SUR2B mRNA levels by 61.4 ± 3.2% (P <
0.001; n = 4) and 84.3 ± 1.2% (P < 0.001; n = 4), respectively.
4.5 Effect of increasing doses of MGO on Kir6.1 mRNA
MGO experiments similar to the ones performed on SUR2B mRNAs were also performed on
the Kir6.1 mRNAs. Kir6.1 mRNA was treated with increasing concentrations (100, 300 and 600
μM) of MGO for 6, 18 and 24 h time periods.
Following a 6 h MGO exposure, a marginal decrease in the levels of Kir6.1 mRNA band
density was observed in response to increasing concentrations of MGO (Fig. 9A). A decrease in
the band density by 2.4 ± 1.3% (n = 3) was observed with 100 μM MGO treatment. A further
increase in the MGO concentration did not lead to a further change in the mRNA band density
(2.4 ± 1.7%, n = 4 with 300 μM and 2.4 ± 0.7%, n = 4 with 600 μM respectively).
At an 18 h time point (Fig. 9B), a 3.4 ± 1.1 % (n = 4) decrease in the Kir6.1 mRNA band
compared with the control value was observed following a 100 µM MGO treatment. An increase
in the MGO dose to 300 and 600 µM led to a slight decrease in the density of Kir6.1 mRNA
bands by 4.7 ± 1.0% (n = 4) and 5.5 ± 1.3% (n = 4) respectively compared to the control.
At 24 h time point (Fig. 9C), a 100 μM MGO treatment lead to decrease in the levels of
Kir6.1 mRNA by 8.5 ± 3.0% (n = 4) compared with the control. Treatment with higher
35

concentrations of MGO produced a decrease in the Kir6.1 mRNA band density by 11.8 ± 2.4%
(n = 4) with 300 μM and 19.1 ± 2.9% (n = 4) with 600 μM MGO treatments.
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Figure 9. Effect of increasing doses of MGO on Kir6.1 mRNA
Net quantitation (NQ) of Kir6.1 mRNA following MGO treatment (100, 300, and 600 µM). A. Exposure
time 6 h. B. Exposure time 18 h. C. Exposure time 24 h. n = 4

The difference in the Kir6.1 mRNA band densities observed between 100, 300 and 600
μM MGO treatments was not significant (P > 0.05). These results suggest that MGO does not
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have an effect on Kir6.1 mRNAs. Increasing the MGO concentrations do not lead to a significant
change in the Kir6.1 mRNA band density.
4.6 Effect of MGO on Kir6.1 mRNA at different exposure times
To determine the time-dependence for the effect of MGO on Kir6.1 mRNA levels, Kir6.1
mRNA was treated with 300 and 600 µM MGO for 6, 18 and 24 h (Fig. 10).
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Figure 10. Effect of MGO on Kir6.1 mRNA at different exposure times
Net quantitation (NQ) of Kir6.1 mRNA at different exposure times (6, 18 and 24 h) following MGO
treatment. A. MGO concentration, 300 μM. B. MGO concentration, 600 μM. n = 4.

A 300 μM MGO treatment (Fig. 10A) caused a marginal decrease in the levels of Kir6.1
mRNA by 2.8 ± 1.7% (n = 3) after a 6 h MGO exposure, while the an increase in the MGO
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exposure time to 18 h caused a slight decrease in the Kir6.1 mRNA levels by 4.7 ± 1.0% (n = 4)
and to 24 h caused a decrease in the mRNA band density by 11.8 ± 2.4% (n = 4).
With a 600 μM MGO treatment (Fig. 10B), a significantly different pattern in the reduction
of Kir6.1 mRNA levels compared to 300 μM MGO treatment was not observed, following a 6,
18 and 24 h exposure times. A slight decrease in the levels of SUR2B mRNA by 2.2 ± 0.7% (n
= 3) after a 6 h MGO exposure, while the MGO exposure for 18 h and 24 h enhanced the
reduction in Kir6.1 mRNA levels by 5.5 ± 1.3% (n = 4) and 19.1 ± 2.9% (n = 4), respectively.
The reduction observed in Kir6.1 mRNA band density was not significant (P > 0.05) thereby
suggesting that MGO does not act on the Kir6.1 mRNA to cause a reduction in Kir6.1 mRNA
levels.
Taken together these results suggest that MGO acts on the vascular KATP channels by
decreasing the expression of KATP channels. MGO acts on the 3’UTR of Kir6.1 mRNA and the
coding region of the SUR2B mRNA to cause a decrease in the levels of KATP channel mRNAs.
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5. DISCUSSION
In the present study, we have found evidence for the disruption of vascular KATP channels
with an MGO exposure, and shown the underlying mechanisms. MGO treatment causes a major
reduction in the Kir6.1 and SUR2B mRNAs and impairs activity of the K ATP channels.
Remarkably, MGO appears to act on the 3’UTR of the Kir6.1 gene and the coding region of the
SUR2B gene, leading to mRNA instability and a loss of functional K ATP channels in plasma
membranes.
Emerging evidence suggests that RCS including MGO play a major role in the development
of diabetic complications in multiple organs and systems (Bourajjaj et al., 2003). Like ROS, RCS
are highly reactive, and can modify proteins, DNAs and lipids via Maillard covalent links,
producing advanced glycation end products (AGEs) (Thornalley et al., 1999). AGEs can cause
direct damages to intracellular cellular structures and act on extracellular AGE receptors,
producing more reactive species in the cytoplasm through intracellular signaling systems
(Brownlee, 2001). When the cellular mechanisms for the detoxification of the RCS are
overwhelmed by their production, the so-called carbonyl stress takes place. The carbonyl stress
has been suggested playing even more important role than oxidative stress in the development of
diabetic vascular complications (Ellis, 2007).
Although the production of RCS is normally controlled by antioxidants, scavengers and their
degrading enzymes, there are circumstances when key molecules for the maintenance of
homeostatic states become defective or dysfunctional, allowing these reactive species to be
overly produced. Membrane potential appears to be one of such mechanisms (Liu and
Gutterman, 2002). Depolarization can open the voltage-activated Ca2+ channels leading to Ca2+
influx (Anzai et al., 2000; Wray et al., 2005). Since K+ channels are the primary regulators of
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membrane potentials, inhibition of the K+ channels results in depolarization and an elevation in
intracellular Ca2+ (Cook et al., 1988). Since several NADPH oxidases for ROS production are
stimulated by elevated intracellular Ca2+ (Brandes et al., 2010; Guzik et al., 2008; Hink et al.,
2001; Zhang et al., 2008), and since RCS and ROS share the antioxidant detoxification systems,
sustained depolarization may augment the production of these reactive species and aggravate
oxidative/carbonyl stress.
The adverse effects of MGO on the vasculature have been studied previously. Most of these
studies, however, are focused on the molecules of endothelium cells. For example, MGO causes
impairment of endothelium-dependent vasorelaxation of rat mesenteric arteries in hyperglycemic
conditions by causing dysfunction of the endothelium (Brouwers et al., 2010). MGO stimulates
the expression of angiopoietin-2 (Ang-2) protein through the covalent modification of the
transcriptional repressor mSin3A causing endothelial cell death in mice (Yao et al., 2007). Our
studies indicate that MGO also acts on K+ channels in VSM cells. The dysfunction of VSM cells
is remarkable as the VSMs regulate vascular tones. The disruption of the key proteins in the
VSMs for vascular tone regulation tends to impair not only membrane potentials and cellular
contractility but also the VSM responses to circulating hormones and neurotransmitters as well
as the local factors released by endothelial cells.
Oxidative stress and carbonyl stress have a close relationship. Firstly, previous studies have
shown that the elevated levels of MGO can lead to oxidative stress by inactivation of antioxidant
enzymes like superoxide dismutase (Desai and Wu, 2008) and glyoxalase (Thornalley, 2003).
Secondly, MGO can cause mitochondrial dysfunction leading to uncontrolled production of ROS
in VSMs (Wang et al., 2009), which plays a role in the progression of diabetic vascular
complications. Thirdly, MGO can promote oxidative stress through AGE receptor (Brownlee,
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2001) and the NF-κB signaling pathway to produce ROS (Wu and Juurlink, 2002). Moreover,
several antioxidant detoxification systems are shared by RCS and ROS. An over-production of
one of the reactive species can compromise the detoxification of the other.
Though MGO can activate the AGE receptor - NF-κB signaling pathway, we feel that this
pathway may not be the underlying mechanism for KATP channel inhibition by MGO for two
reasons: 1) Our in-vitro assay, in which all the signaling components are missing, shows that
MGO can cause mRNA degradation, indicating a direct action rather than an indirect action via
signaling pathways. 2) In our previous studies, we have shown that by activating the NF-κB
signaling pathway lipopolysaccharides augment, rather than suppress, the expression of vascular
KATP channel mRNAs (Shi et al., 2010).
Our studies suggest that the vascular KATP channel is indeed inhibited by MGO directly. We
have found that an exposure to micromolar concentrations of MGO produces a marked
depression of the KATP currents. Previous studies have shown that plasma MGO levels range
from 14.2 µM to 33.6 µM in healthy rats (Wang et al., 2004). Several orders of elevation in the
MGO levels are expected to take place in persistent hyperglycemia (Chang and Wu, 2006). The
MGO levels may be even higher in local tissues than in the plasma as a result of immediate
release from cells. Indeed, the MGO levels are as high as 300 µM when measured in cultured
mammalian cells (Chaplen et al., 1998). The concentrations of MGO used for our study are
within the physiological range in diabetic conditions.
Our detailed analysis of the mechanisms underlying the decreases in the Kir6.1 and SUR2B
transcripts indicates that mRNA instability causes the reduction in the levels of KATP channel
mRNAs. Interestingly, two completely different mechanisms are in action in the process. MGO
causes the instability of KATP channel mRNAs by targeting at the 3’UTR of Kir6.1 gene and
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acting directly on the coding region of SUR2B transcripts. To our knowledge, this is the first
demonstration of the direct targeting of ion channel mRNA and 3’UTR by MGO.
Because of the intertwining relationship of ROS and RCS, it is necessary to elucidate
whether the cellular dysfunction seen in MGO treatment is produced by MGO itself or mediated
via the associated oxidative stress. Our current studies support that the mRNAs of Kir6.1 and
SUR2B are directly targeted by MGO, while our previous studies have shown that vascular KATP
channel protein is directly targeted in oxidative stress conditions through the post-translational
regulation S-glutathionylation (Yang et al., 2011; Yang et al., 2010). Therefore, the data shown
in the present studies indicate that MGO has a unique effect on the vascular K ATP channels,
though its adverse consequence on channel inhibition is similar to that of oxidative stress.
Therefore, carbonyl stress and oxidative stress seem to work synergistically on the vascular K ATP
channels. It is likely that the vascular KATP channels are disrupted in oxidative/carbonyl stress at
both protein and mRNA levels, resulting in abnormalities in VMS contractility, dysfunction in
vascular responses to circulating/local vasoactive regulators, and exacerbation of oxidative/
carbonyl stress.
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